Property-Based Optimization of Hydroxamate-Based gamma-Lactam HDAC Inhibitors to Improve Their Metabolic Stability and Pharmacokinetic Profiles
- Authors
- Choi, Eunhyun; Lee, Chulho; Cho, Misun; Seo, Jeong Jea; Yang, Jee Sun; Oh, Soo Jin; Lee, Kiho; Park, Song-Kyu; Kim, Hwan Mook; Kwon, Ho Jeong; Han, Gyoonhee
- Issue Date
- 13-12월-2012
- Publisher
- AMER CHEMICAL SOC
- Citation
- JOURNAL OF MEDICINAL CHEMISTRY, v.55, no.23, pp.10766 - 10770
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF MEDICINAL CHEMISTRY
- Volume
- 55
- Number
- 23
- Start Page
- 10766
- End Page
- 10770
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/106661
- DOI
- 10.1021/jm3009376
- ISSN
- 0022-2623
- Abstract
- Hydroxamate-based HDAC inhibitors have promising anticancer activities but metabolic instability and poor pharmacokinetics leading to poor in vivo results. QSAR and PK studies of HDAC inhibitors showed that a gamma-lactam core and a modified cap group, including halo, alkyl, and alkoxy groups with various carbon chain linkers, improved HDAC inhibition and metabolic stability. The biological properties of the gamma-lactam HDAC inhibitors were evaluated; the compound designated 8f had potent anticancer activity and high oral bioavailability.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.